Provided by Tiger Fintech (Singapore) Pte. Ltd.

AI Chips

1,291.15
-17.7502-1.36%
Number of Gainers:5
Number of Losers:10
Number of Flat:1
PE:- -
High:1,318.10
Open:1,310.06
Low:1,282.19
Close:1,308.90
Loading ...

TSMC could face fine of $1B or more from U.S. Huawei probe, Reuters says

TIPRANKS
·
08 Apr

RL Vs GIII: Which Textile Apparel is a Smarter Long-Term Investment?

Zacks
·
08 Apr

Things ‘appear to be worsening’ in China for Tesla, says GLJ Research

TIPRANKS
·
08 Apr

Amazon’s Zoox begins robotaxi testing in Los Angeles

TIPRANKS
·
08 Apr

Camtek Earns Intel's 2025 EPIC Supplier Award

PR Newswire
·
08 Apr

Ultra Clean Earns Intel's 2025 EPIC Supplier Award

PR Newswire
·
08 Apr

Advanced Micro Devices Facing Concerns Over China AI Business Sustainability, KeyBanc Says

MT Newswires Live
·
08 Apr

Value of Second-Hand Tesla Vehicles Plunge But Don’t Go Blaming it on Musk’s Political Baggage

TIPRANKS
·
08 Apr

Musk Calls Trump's Trade Adviser a 'Moron' -- WSJ

Dow Jones
·
08 Apr

Outlook Therapeutics Says FDA Accepts Biologics License Application for Wet AMD Treatment

MT Newswires Live
·
08 Apr

Tesla ‘the most vertically integrated auto manufacturer in America,’ Musk says

TIPRANKS
·
08 Apr

NVIDIA Speeds Up Meta's Llama 4 AI Models With Blackwell GPUs, Hitting 40,000 Tokens Per Second

GuruFocus
·
08 Apr

Should Value Investors Buy Baidu (BIDU) Stock?

Zacks
·
08 Apr

Broadcom Shares up 9.1% After Co Announces $10 Billion Share Buyback Plan

THOMSON REUTERS
·
08 Apr

Tesla's Energy & Storage Unit is Thriving: Is it the Only Bright Spot?

Zacks
·
08 Apr

International Business Machines (IBM) Gets a Buy from Evercore ISI

TIPRANKS
·
08 Apr

Intel Corporation (INTC): A Bull Case Theory

Insider Monkey
·
08 Apr

Dell Technologies Unveils Infrastructure Innovations Built to Power Modern AI-Ready Data Centers

Business Wire
·
08 Apr

Walgreens turnaround still in its early stages, says CEO, as buyout looms

Dow Jones
·
08 Apr

Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire
·
08 Apr